These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36352088)

  • 1. Two autopsy cases of wild-type transthyretin cardiac amyloidosis who died 10 days after technetium-99m-pyrophosphate scintigraphy.
    Takahashi K; Morioka H; Sasaki D; Yamamura N; Kitazawa S; Ueda M; Sakaue T; Enomoto D; Uemura S; Okura T; Ikeda S
    J Nucl Cardiol; 2023 Oct; 30(5):2215-2221. PubMed ID: 36352088
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of disappearing amyloid on technetium pyrophosphate scan.
    Wang A; Mahmood U; Tang X; Jain D; Pan S
    J Nucl Cardiol; 2023 Oct; 30(5):1986-1991. PubMed ID: 37340232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparable image interpretation of 1- and 3-hour technetium-99m HDP scintigraphy for transthyretin cardiac amyloidosis.
    Malhotra S; Singh V; Pilati S; Trepashko D
    J Nucl Cardiol; 2022 Aug; 29(4):2020-2023. PubMed ID: 35676550
    [No Abstract]   [Full Text] [Related]  

  • 4. Validation of the Kumamoto criteria for prediction of
    Ochi Y; Kubo T; Baba Y; Ueda M; Miyagawa K; Noguchi T; Hirota T; Yamasaki N; Kitaoka H
    J Cardiol; 2021 Feb; 77(2):124-130. PubMed ID: 33132078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In the thick of it: hereditary cardiac amyloidosis identified by
    Smiley D; Einstein AJ; Chan N; Mintz A; Santana DD; Shetty M; Sekulic M; Goldner K; Wall J; Helmke S; Maurer MS
    J Nucl Cardiol; 2023 Jun; 30(3):1258-1262. PubMed ID: 37138173
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiopharmaceutical supply disruptions and the use of
    Miller EJ; Campisi R; Shah NR; McMahon S; Cuddy S; Gallegos-Kattan C; Maurer MS; Damy T; Slart RHJA; Bhatia K; Einstein AJ
    J Nucl Cardiol; 2022 Oct; 29(5):2748-2760. PubMed ID: 35838892
    [No Abstract]   [Full Text] [Related]  

  • 7. Serial
    Okada A; Tateishi E; Morita Y; Ohta-Ogo K; Izumi C
    Circ Heart Fail; 2023 Jan; 16(1):e009595. PubMed ID: 36541213
    [No Abstract]   [Full Text] [Related]  

  • 8. Technetium-99m-pyrophosphate imaging-based computed tomography-guided core-needle biopsy of internal oblique muscle in wild-type transthyretin cardiac amyloidosis.
    Takahashi K; Hiratsuka Y; Iwamura T; Sasaki D; Yamamura N; Kitazawa S; Ueda M; Morioka H; Okura T; Enomoto D; Uemura S; Kono T; Sakaue T; Ikeda S
    Amyloid; 2024 Mar; 31(1):12-21. PubMed ID: 37486102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive detection and differentiation of cardiac amyloidosis using
    Takasone K; Katoh N; Takahashi Y; Abe R; Ezawa N; Yoshinaga T; Yanagisawa S; Yazaki M; Oguchi K; Koyama J; Sekijima Y
    Amyloid; 2020 Dec; 27(4):266-274. PubMed ID: 32722948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Noninvasive diagnosis of cardiac involvement by technetium-99m-pyrophosphate (Tc-99m PYP) myocardial scintigraphy in 2 cases of familial amyloid polyneuropathy and 1 case of secondary amyloidosis].
    Takezaki M; Ishida Y; Morozumi T; Tani A; Sato H; Hori M; Kitabatake A; Kamada T; Kimura K; Kozuka T
    Kaku Igaku; 1989 Dec; 26(12):1537-43. PubMed ID: 2560088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of technetium pyrophosphate scintigraphy in demonstrating cardiac amyloidosis in persons aged 85 years and older.
    Goldstein SA; Lindsay J; Chandeysson PL; Nolan NG
    Am J Cardiol; 1989 Mar; 63(11):752-3. PubMed ID: 2538049
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnostic significance of technetium-99m-pyrophosphate, technetium-99m-methylene diphosphonate and gallium-67-citrate scintigraphy in amyloid heart disease--a study with AL amyloidosis and familial amyloid polyneuropathy].
    Hongo M; Misawa T; Yamada H; Hirayama J; Okubo S; Fujii T; Kusama S; Ikeda S
    Nihon Naika Gakkai Zasshi; 1986 Jan; 75(1):1-8. PubMed ID: 3009667
    [No Abstract]   [Full Text] [Related]  

  • 13. Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis.
    Gertz MA; Brown ML; Hauser MF; Kyle RA
    Arch Intern Med; 1987 Jun; 147(6):1039-44. PubMed ID: 3036031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium 99m-pyrophosphate scintigraphy in amyloid cardiomyopathy.
    Ptacin MJ; Bamrah V; Duthie E
    Wis Med J; 1985 Mar; 84(3):25-7. PubMed ID: 2986368
    [No Abstract]   [Full Text] [Related]  

  • 15. Echocardiographic score for the screening of cardiac amyloidosis with positive 99m technetium pyrophosphate scintigraphy result.
    Nagai T; Horinouchi H; Hashimoto K; Ichiji T; Yoshioka K; Hashimoto J; Ikari Y
    Echocardiography; 2023 Jul; 40(7):634-641. PubMed ID: 37243310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis.
    Falk RH; Lee VW; Rubinow A; Hood WB; Cohen AS
    Am J Cardiol; 1983 Mar; 51(5):826-30. PubMed ID: 6299087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Uptake of technetium-99m pyrophosphate in cardiac amyloidosis].
    Montes J; López L; Martín F; Pinedo JI; Galván R; Ortiz Berrocal J
    Rev Esp Cardiol; 1985; 38(4):300. PubMed ID: 2996085
    [No Abstract]   [Full Text] [Related]  

  • 18. Wild type cardiac amyloidosis: is it time to order a nuclear technetium pyrophosphate SPECT imaging study?
    Shen CP; Vanichsarn CT; Pandey AC; Billick K; Rubenson DS; Mohan RC; Heywood JT; Srivastava AV
    Int J Cardiovasc Imaging; 2023 Jan; 39(1):201-208. PubMed ID: 36598681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid deposit corresponds to technetium-99m-pyrophosphate accumulation in abdominal fat of patients with transthyretin cardiac amyloidosis.
    Takahashi K; Sasaki D; Yamashita M; Sakaue T; Enomoto D; Morioka H; Uemura S; Okura T; Ikeda S; Kono T; Hiratsuka Y; Saijo A; Yamamura N; Kitazawa S; Yamashita T; Ueda M
    J Nucl Cardiol; 2022 Dec; 29(6):3126-3136. PubMed ID: 34964085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case of Biopsy-Proven Wild-Type ATTR Cardiac Amyloidosis With Abnormal CMR and Negative
    Yabut J; Nadig V; Arora S; Hirsch D; Duvall WL
    Circ Cardiovasc Imaging; 2024 Jan; 17(1):e015734. PubMed ID: 38146653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.